More News
30 September 2019
Vertex and Ribometrix Establish Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics27 September 2019
Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform27 September 2019
Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo27 September 2019
Harvard University Establishes mRna Immunotherapy Research Collaboration With Moderna25 September 2019
Evotec and Takeda enter collaboration agreement to discover clinical candidates across multiple therapeutic areas24 September 2019
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs24 September 2019
Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals20 September 2019
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases19 September 2019
Allogene Therapeutics Enters Research Collaboration Directed at Enhancing Future Cancer Immunotherapies19 September 2019
Y-Trap Enters Collaboration with Merck KGaA, Darmstadt, Germany, to Develop Novel Antibody-Ligand Traps for Immuno-Oncology17 September 2019
Oncoheroes Biosciences Inc. and Boehringer Ingelheim International GmbH sign exclusive licensing agreement for volasertib16 September 2019
Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed12 September 2019
Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK12 September 2019
Tubulis and Glycotope Announce Research and Feasibility Agreement for the Discovery of Antibody Drug Conjugates10 September 2019
Genmab and Tempus Enter into Strategic Collaboration Agreement9 September 2019
Alexion and BridgeBio Announce Japanese License Agreement for Eidos’ Transthyretin Amyloidosis (ATTR) Investigational Medicine8 September 2019
RNA-Targeted Small Molecules: new report about hot area of emerging discovery technologies financed by excited investors and pharma partners6 September 2019
IFM Therapeutics Announces Collaboration and Exclusive Option Agreement for cGAS/STING-Focused Subsidiary, IFM Due5 September 2019
Schrödinger Announces Collaboration with AstraZeneca to Deploy Advanced Computing Technology for Drug Discovery5 September 2019
Maruho and X-Chem Announce Drug Discovery Collaboration4 September 2019
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor CompoundNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports